Drug profile · INN
albuterol sulfate
PROVENTIL
albuterol sulfate (PROVENTIL) is a beta-2 adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — albuterol sulfate
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 0
- Programs
- 11
- Data quality
- 0.89
Quick answer
albuterol sulfate (PROVENTIL) is a beta-2 adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is albuterol sulfate?
albuterol sulfate (PROVENTIL) is a beta-2 adrenergic receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for albuterol sulfate?
PROVENTIL is a marketed brand name for albuterol sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of albuterol sulfate?
albuterol sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.